The Bid & Ask

Quotations, Dispatches, and the Daily Tape

Thursday, August 13, 2026

Subject of the day

RVTY

Concerning the House

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

United States · www.revvity.com

The Long Run

FY 2010–2025 · 16 years

LineLatestCAGRTrend
Revenue$2.86B+3.5%
Gross profit$693.19M+13.2%
Operating income$300.56M+4.9%
Net income$693.09M+15.0%
Cash from ops$582.93M+9.5%
Quotation

$117.50

-0.38 (-0.3%)

52w hi$117.88
52w lo$82.21
Vol883.91K
As ofAug 13
The Verdict

Hold

Our score +0.27

Short+0.23
Medium+0.40
Long+0.12

computed 2026-08-13

By the Numbers

Revvity, Inc.

Healthcare · Diagnostics & Research

Market cap$13.11B
Enterprise value$15.48B
Trailing P/E56.76x
Forward P/E19.94x
EV / EBITDA17.85x
P / S (ttm)4.50x
Profit margin8.2%
Return on equity3.2%
Revenue growth+1.3%
Earnings growth+1.1%
Debt / equity46.23
Risk Metrics
Beta vs SPX1.13
Corr SPX0.50
Annual vol36.8%
Annual ret+6.1%
Sharpe0.16
Max DD-35.6%

Window: 504 trading days (504 obs)

Layer Breakdown
LayerRawContribution
Fundamental+0.12
Sector+0.12
Technical+0.19
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-08-13

Recent Sessions
DateOpenHighLowCloseVol
Aug 13$118.25$118.34$115.67$117.50883.91K
Aug 12$115.21$117.94$114.64$117.881.21M
Aug 11$115.83$116.84$115.10$115.731.29M
Aug 10$114.22$116.74$112.68$116.021.25M
Aug 7$114.98$115.51$113.74$114.661.03M